文献速递心血管胸部MR

基于心脏磁共振估算结缔组织病相关肺动脉高压的平均肺动脉压和肺血管阻力

CMR-based estimation of mean pulmonary arterial pressure and pulmonary vascular resistance in connective tissue disease-associated pulmonary arterial hypertension.
PubMed 文献 · Clin Radiol · 2025-12-02

本研究回顾性纳入144例结缔组织病患者,其中50例无肺动脉高压、70例结缔组织病相关肺动脉高压用于建模、24例用于验证,所有患者均在7天内完成心脏磁共振和右心导管检查。研究建立了基于心室质量指数、室间隔形态和右心室功能参数的模型来估算平均肺动脉压和肺血管阻力,验证显示与右心导管结果良好相关,Bland-Altman分析证实一致性。

要点

  • 心室质量指数、室间隔角和室间隔曲度与右心导管测得的平均肺动脉压强相关(r=0.73、0.71和-0.69,均P<0.01)。
  • 右心室射血分数阈值为22%:当RVEF>22%时,mPAP与RVEF呈负相关(P<0.001);当RVEF≤22%时,两者无相关性(P=0.657)。
  • 在RVEF>22%条件下建立的mPAP预测模型为:32.454 + (42.616 × VMI) - (19.276 × IVS曲度);PVR预测模型为:8.664 + (28.495 × VMI) - (0.053 × RVESVI) - (7.206 × RV SV/ESV)。

核心结论

  • 心脏磁共振可为结缔组织病相关肺动脉高压患者提供无创估算平均肺动脉压和肺血管阻力的方法,可能在肺血流动力学评估中具有应用价值。

研究设计与样本

  • 回顾性研究,纳入144例结缔组织病患者(50例无肺动脉高压、70例结缔组织病相关肺动脉高压建模、24例结缔组织病相关肺动脉高压验证),时间范围为2017年9月至2024年3月,所有患者均在7天内完成心脏磁共振和右心导管检查。

关键影像表现/征象

  • 心室质量指数、室间隔角和室间隔曲度与右心导管测得的平均肺动脉压强相关(r=0.73、0.71和-0.69,均P<0.01)。
  • 当右心室射血分数>22%时,平均肺动脉压与右心室射血分数呈负相关(P<0.001);当右心室射血分数≤22%时,两者无相关性(P=0.657)。

诊断标准与关键数值

  • 右心室射血分数阈值22%:RVEF>22%时mPAP与RVEF负相关(P<0.001),RVEF≤22%时无相关性(P=0.657)。
  • 在RVEF>22%条件下,预测mPAP的CMR模型为:32.454 + (42.616 × VMI) - (19.276 × IVS曲度)。
  • 预测PVR的CMR模型为:8.664 + (28.495 × VMI) - (0.053 × RVESVI) - (7.206 × RV SV/ESV)。
  • 验证结果显示与右心导管相关性良好:mPAP r=0.679,PVR r=0.625,均P≤0.001;Bland-Altman分析证实CMR与RHC一致性。

临床应用与阅片要点

  • 在结缔组织病患者中,可测量心室质量指数、室间隔角和室间隔曲度等CMR参数,这些参数与右心导管测得的平均肺动脉压强相关。
  • 应用CMR模型估算mPAP和PVR时,需注意右心室射血分数>22%的条件,该条件下模型基于VMI、IVS曲度、RVESVI和RV SV/ESV等参数建立。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To estimate mean pulmonary arterial pressure (mPAP) and pulmonary vascular resistance (PVR) using cardiac magnetic resonance (CMR) in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH).

MATERIALS AND METHODS: This retrospective study included 144 CTD patients (50 CTD-nonPAH, 70 CTD-PAH derivation, 24 CTD-PAH validation) from September 2017 to March 2024. Patients underwent both CMR and right heart catheterization (RHC) within 7 days. CMR parameters, including ventricular volumes, and pulmonary arterial hemodynamics, were measured and compared with RHC-derived mPAP and PVR. Multivariate regression models for mPAP and PVR were developed and validated. Spearman's correlation and Bland-Altman analysis were used to assess model accuracy.

RESULTS: Ventricular mass index (VMI), interventricular septum (IVS) angle, and IVS curvature correlated strongly with RHC-based mPAP (r=0.73, 0.71, and -0.69; all P<0.01). A right ventricular ejection fraction (RVEF) threshold of 22 % was identified: when RVEF > 22 %, mPAP and RVEF were negatively correlated (P<0.001); no correlation was found when RVEF ≤ 22 % (P=0.657). For RVEF > 22 %, the following CMR model was established to predict mPAP: 32.454 + (42.616 × VMI) - (19.276 × IVS curvature). Another CMR model for predicting PVR was developed: 8.664 + (28.495 × VMI) - (0.053 × RVESVI) - (7.206 × RV SV/ESV). Validation demonstrated good correlations with RHC (mPAP: r=0.679; PVR: r=0.625, both P≤0.001). Bland-Altman analysis confirmed agreement between CMR and RHC.

CONCLUSIONS: CMR provides a noninvasive method for estimating mPAP and PVR in CTD-PAH patients, with potential utility in pulmonary hemodynamic assessment.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Ma K, Zhu Y, Liu W, et al. CMR-based estimation of mean pulmonary arterial pressure and pulmonary vascular resistance in connective tissue disease-associated pulmonary arterial hypertension. Clin Radiol. 2025. PMID: 41520632. doi:10.1016/j.crad.2025.107199

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。